ORPH.IR
Get informed when a big investor buys or sells
+ Follow| Market cap | $75.45 Million |
|---|---|
| Enterprise Value | $45.02 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $0.02 |
| Beta | 0.75 |
| Outstanding Shares | 680,371,877 |
| P/E Ratio | -3.33 |
|---|---|
| PEG | 5.98 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 0.38 |
| Enterprise Value to EBIT | 1.99 |
| Enterprise Value to Net Income | 1 |
| Total Debt to Enterprise | 0.31 |
| Debt to Equity | 0.31 |
No data
No data available for the latest quarter.
No data available for the latest quarter.
No data
hVIVO plc (HVO) operates as a premier full-service Contract Research Organisation (CRO) focused on early-phase clinical development, globally recognized as the leader in human challenge trials. The company provides a complete spectrum of...